Table 3.
Estimated impact of the UK government’s sugar reduction programme on quality adjusted life years (QALYs), disease burden, and healthcare costs over 10 years
| Characteristic |
Mean (2.5th-97.5th centile; uncertainty interval) | |
|---|---|---|
| Male population | Female population | |
| QALYs (No) | 23 874 (21 194 to 26 369) | 27 855 (24 573 to 30 873) |
| NHS costs (£m)* | −£124.2 (−£139.2 to −£108.1) | −£161.6 (−£180.6 to −£141.6) |
| Disease burden (No of cases) | ||
| Cardiovascular disease | −1591 (−1742 to −1433) | −1920 (−2118 to −1733) |
| Stroke | −881 (−987 to −771) | −1741 (−1947 to −1524) |
| Diabetes | −64 979 (−73 523 to −55 698) | −89 571 (−101 081 to −76 925) |
| Breast cancer | 0 | −2872 (−3759 to −1972) |
| Colorectal cancer | −4220 (−4845 to −3575) | −1573 (−2251 to −891) |
| Lung cancer | 21 (18 to 23) | 11 (10 to 12) |
| Stomach cancer | 3 (3 to 4) | 1 (1 to 2) |
| Cirrhosis | −2982 (−3649 to −2248) | −2620 (−3216 to −1961) |
| Pancreas cancer | −251 (−335 to −166) | −297 (−397 to −196) |
| Kidney cancer | −863 (−1152 to −562) | −865 (−1060 to −672) |
| Liver cancer | −643 (−873 to −402) | −425 (−576 to −265) |
*
£1=€1.17; $1.31.